These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 24325405)

  • 101. Interferon free therapy with direct acting antivirals for HCV.
    Asselah T; Marcellin P
    Liver Int; 2013 Feb; 33 Suppl 1():93-104. PubMed ID: 23286852
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.
    Meng Q; Rani MR; Sugalski JM; Judge CJ; Phat S; Rodriguez B; Blanton RE; Anthony DD
    J Infect Dis; 2014 May; 209(10):1591-601. PubMed ID: 24302757
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Impact of IL28B genetic variant's and viral genotype on treatment outcome of hepatitis C infected patients.
    Khan MS; Shoukat A; Mudassar S; Kawoosa Z; Shah AH; Zargar SA
    J Infect Dev Ctries; 2018 Sep; 12(9):762-770. PubMed ID: 31999635
    [TBL] [Abstract][Full Text] [Related]  

  • 104. IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients.
    Hsu CS; Hsu SJ; Liu WL; Chen CL; Liu CJ; Chen PJ; Chen DS; Kao JH
    Antivir Ther; 2013; 18(4):599-606. PubMed ID: 23296193
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Management of hepatitis C virus infection: the basics.
    Naggie S
    Top Antivir Med; 2012 Dec; 20(5):154-61. PubMed ID: 23363693
    [TBL] [Abstract][Full Text] [Related]  

  • 106. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
    Thong VD; Wasitthankasem R; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2015; 10(5):e0125400. PubMed ID: 25938236
    [TBL] [Abstract][Full Text] [Related]  

  • 108. IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients.
    Ohnishi M; Tsuge M; Kohno T; Zhang Y; Abe H; Hyogo H; Kimura Y; Miki D; Hiraga N; Imamura M; Takahashi S; Ochi H; Hayes CN; Tanaka S; Arihiro K; Chayama K
    J Gastroenterol; 2012 Jul; 47(7):834-44. PubMed ID: 22350701
    [TBL] [Abstract][Full Text] [Related]  

  • 109. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
    Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
    J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype.
    Motomura T; Shirabe K; Furusyo N; Yoshizumi T; Ikegami T; Soejima Y; Akahoshi T; Tomikawa M; Fukuhara T; Hayashi J; Maehara Y
    BMC Gastroenterol; 2012 Nov; 12():158. PubMed ID: 23145809
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection.
    Al-Qahtani A; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khan MQ; Albenmousa A; Khalaf N; Viswan N; Al-Ahdal MN
    J Immunol Res; 2015; 2015():768470. PubMed ID: 25811035
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
    Ge D; Fellay J; Thompson AJ; Simon JS; Shianna KV; Urban TJ; Heinzen EL; Qiu P; Bertelsen AH; Muir AJ; Sulkowski M; McHutchison JG; Goldstein DB
    Nature; 2009 Sep; 461(7262):399-401. PubMed ID: 19684573
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
    Kawaguchi-Suzuki M; Frye RF
    Pharmacotherapy; 2014 Feb; 34(2):185-201. PubMed ID: 24114761
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
    Tanaka Y; Nishida N; Sugiyama M; Kurosaki M; Matsuura K; Sakamoto N; Nakagawa M; Korenaga M; Hino K; Hige S; Ito Y; Mita E; Tanaka E; Mochida S; Murawaki Y; Honda M; Sakai A; Hiasa Y; Nishiguchi S; Koike A; Sakaida I; Imamura M; Ito K; Yano K; Masaki N; Sugauchi F; Izumi N; Tokunaga K; Mizokami M
    Nat Genet; 2009 Oct; 41(10):1105-9. PubMed ID: 19749757
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6.
    Seto WK; Tanaka Y; Liu K; Lai CL; Yuen MF
    Am J Gastroenterol; 2011 May; 106(5):1007-8. PubMed ID: 21540909
    [No Abstract]   [Full Text] [Related]  

  • 116. Boceprevir for chronic HCV genotype 1 infection.
    Hsu CS; Kao JH
    N Engl J Med; 2011 Jul; 365(2):176-7; author reply 177-8. PubMed ID: 21751913
    [No Abstract]   [Full Text] [Related]  

  • 117. A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan.
    Zia A; Ali M; Aziz H; Zia M; Shinwari ZK; Raza A
    Infect Dis Poverty; 2018 Feb; 7(1):11. PubMed ID: 29429413
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Viral hepatitis C gets personal--the value of human genomics to public health.
    Zhang L; Gwinn M; Hu DJ
    Public Health Genomics; 2013; 16(4):192-7. PubMed ID: 23859951
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients.
    Mohamed Abdelnajid D; Elmowafy AY; Rostaing L; Elrakaiby MT
    Medicine (Baltimore); 2023 Jul; 102(28):e34125. PubMed ID: 37443472
    [TBL] [Abstract][Full Text] [Related]  

  • 120. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
    Bochud PY; Bibert S; Kutalik Z; Patin E; Guergnon J; Nalpas B; Goossens N; Kuske L; Müllhaupt B; Gerlach T; Heim MH; Moradpour D; Cerny A; Malinverni R; Regenass S; Dollenmaier G; Hirsch H; Martinetti G; Gorgiewski M; Bourlière M; Poynard T; Theodorou I; Abel L; Pol S; Dufour JF; Negro F; ;
    Hepatology; 2012 Feb; 55(2):384-94. PubMed ID: 22180014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.